Precision Therapy for Genetic Dilated Cardiomyopathy a Growing Possibility

(MedPage Today) — MINNEAPOLIS — The small-molecule drug candidate danicamtiv showed promise for activating myosin in gene-related dilated cardiomyopathy (DCM), based on a small phase IIa study.
Suggesting boosted ventricular and atrial function…